Ayman Khairy Mohamed Hassan, MD, PhD, FESC

Lecturer of Cardiovascular Medicine
Department of Cardiology
Assiut University Hospitals
Assiut 71526, Egypt

Biography

Education:

• July 2010: MD in cardiovascular medicine, Faculty of Medicine, Assiut University, Egypt
• January 2009: PhD in cardiovascular medicine, Faculty of Medicine, Leiden University , the Netherlands
• May 2004: Master Degree (M.Sc) in Cardiovascular medicine, Faculty of Medicine, Assiut University, Egypt
• September 1999: M.B.B.Ch in medicine and surgery, Faculty of Medicine, Assiut University, Egypt

Employment History:

• 9/2012-Present: Vice-director of Assiut University Hospitals, Chief of Health Care Quality Unite (HCQU), Assiut University Hospitals
• 9/2010- Present: Lecturer of cardiology, Assiut University
• 6/2009 – 9/2012: Executive Director of Assiut university catheterization laboratory, Assiut University
• 11/2004 to 8/2010: Associate lecturer, Assiut University
• 3/2004 – 11/2004: Demonstrator, Assiut University
• 3/2001 – 3/2004: Resident in Cardiology Department (Registrar), Assiut University Hospitals
• 3/2000 to 2/2001: House officer, Assiut University Hospitals

Research Interest

His research interests include: Evidence based Management of acute coronary syndromes and primary angioplasty, Hospital quality and accreditation systems.

Scientific Activities

Membership in Professional Societies:

• 2008-Present: Fellow of European Society of Cardiology
• 2008-Present: Fellow of European Association of Percutaneous Cardiovascular interventions (EAPCI)
• 2005-Present: Membership of the Egyptian Society of Cardiology
• 2005-Present: Member of the Egyptian Society of Atherosclerosis
• 2002-Present: Member & Fundador of the Egyptian Resuscitation Council
• 2002-Present: Member of European Resuscitation Council as an Official instructor
• 1999-Present: Membership of the Egyptian Medical Syndicate (EMS)

Publications

1. Hassan AKM, Liem SS, van der Kley F, et al. In-Ambulance Abciximab Administration in STEMI Patients Prior to Primary PCI is Associated with Smaller Infarct Size, Improved LV Function and Lower Incidence of Heart Failure: Results from the Leiden MISSION! Acute Myocardial Infarction Treatment Optimization Program. Catheterization and Cardiovascular Interventions. 2009; 74(2): 335-343. doi: 10.1002/ccd.21980
2. Hassan AKM, Jukema W, van der Laarse A, et al. Incidence, patient’s characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment. EuroInterv.2009; 4: 662-668. doi: 10.4244/EIJV4I5A110
3. Hassan AKM, Bergheanu SC, Stijnen T, et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J.2010: 31(10): 1172-1180. doi: 10.1093/eurheartj/ehn553
4. Hassan AKM, Bergheanu S, Stijnen T, et al. Late Acquired Stent Malapposition is Higher After Drug-Eluting Stent Compared to Bare-Metal Stent Implantation and is Associated with (Very) Late Stent Thrombosis: Meta-Analysis and Systematic Review. American Journal of Cardiology. 2008; 102(8A): 1981. doi: 10.1093/eurheartj/ehn553
5. Bergheanu SC, Hassan AKM, Jukema JW. Late stent malapposition: innocent phenomenon or major risk marker? European Heart Journal. 2010; 31(2): 260-261. doi: 10.1093/eurheartj/ehp510
6. Hassan AKM, Bergheanu SC, Hasan-Ali H, et al. Usefulness of peak troponin-t to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. American Journal of Cardiology. 2009; 103(6): 779-784. doi: 10.1016/j.amjcard.2008.11.031
7. Hassan AKM, Liem SS, van der Kley F, et al. In-ambulance Abciximab Facilitated Primary PCI is Associated with Smaller Enzymatic Infarct Size, Improved LV Function and Lower Incidence of Heart Failure at One Year Clinical Follow-up. American Journal of Cardiology. 2008; 102(8A): 671.
8. Bergheanu SC, Van der Hoeven BL, Hassan AKM, et al. Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stents. Acta Cardiologica. 2009; 64(5): 611-616.
9. Hasan-Ali H, Hassan AKM. Tissue-doppler assessment of the changes in longitudinal left and right ventricular functions after percutaneous mitral valvotomy. JACC. 2011; 58(20): B214-B215.
10. Hassan AKM, Hasan-Ali H, Demetry SR, et al. A new femoral compression device compared with manual compression for bleeding control after coronary diagnostic catheterizations. The Egypt Heart J. 2013; 66(3): 233-239. doi: 10.1016/j.ehj.2013.11.001
11. Othman AAA, Tohamy AM, Hassan AKM. Pulmonary embolism presented by syncope in a low-risk patient: a case report. 2013; 2: 257. doi: 10.12688/f1000research.2-257.v1
12. Hassan AKM, Hasan-Ali H, Demetry SR, et al. Early sheath removal after percutaneous coronary intervention using Assiut Femoral Compression Device is feasible and safe. Results of a randomized controlled trial. The Egypt Heart J. 2014; 67(1): 69-77. doi: 10.1016/j.ehj.2014.10.003
13. Hassan AKM, Demetry SR, Agban GW. Can exercise capacity assessed by the 6 minute walk test predict the development of major adverse cardiac events in patients with stemi after fibrinolysis? PLoS One. 2014; 9(6): e99035. doi: 10.1371/journal.pone.0099035
14. Abdel Rahman H, Hassan AKM, Abosetta AHS, et al. Increased left atrial stiffness in patients with atrial fibrillation detected by left atrial speckle tracking echocardiography. The Egyptian Heart Journal.2014. doi: 10.1016/j.ehj.2014.11.006